Status:
COMPLETED
Cardiac Rehabilitation Program in Peripheral Arterial Disease
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main purpose of this study is to see if it is safe and feasible to use cardiac rehabilitation (CR) in patients with peripheral arterial disease (PAD) after successful revascularization. This study...
Eligibility Criteria
Inclusion
- Patients with PAD post-revascularization (stent, angioplasty, or bypass).
- Patients must have the ability to ambulate safely without assistance and should not have plans for undergoing further staged revascularization procedures.
Exclusion
- Below or above the knee amputation.
- Underlying cardiopulmonary or other co-morbidity that would be an exclusion under currently approved standard CR protocols at the University of Kansas Medical Center (KUMC).
- Unfavorable short term prognosis and limited life expectancy (\<2 years)
- Awaiting a planned staged revascularization in same or other leg (patients will be eligible once no further procedures are planned).
- Prior history of having dropped out of CR without completing.
- Unwilling to consent for all aspects of CR or study participation.
- Unable to come for CR (this will exclude patients who live far away or have no means to travel to the CR facility).
- Pregnancy
Key Trial Info
Start Date :
April 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 11 2019
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03251391
Start Date
April 13 2017
End Date
May 11 2019
Last Update
September 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160